| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d5de9a1dac6b033c4643bb236ef4df3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9711eaff902e1e67e9b983f7b9c075fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 |
| filingDate |
2016-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_850cb52ac3cfe345ec64ff9d387a58df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9fa670d0fdefcbc9e78a15c20bf061e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d9b74ebbdc4a6924a8340269fe6ddcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_741a5d9af55a54835694b874279b45c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_065a22b28916a3161a242d239bc76fff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcfb86e2e3a47a3ecc19ed3b1212da07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_052a46f14cd8ed03c0c8d369d5d3c2ff |
| publicationDate |
2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10682396-B2 |
| titleOfInvention |
Controlled release system for pulmonary delivery of surfactant protein D |
| abstract |
A controlled release system includes surfactant protein D (SPD) and a carrier suitable for controlled release that can be polylactic-co-glycolic acid (PLGA). The system can be in the form of a nanoparticle. A pharmaceutical composition includes the system and a pharmaceutically acceptable carrier. Methods of treatment of a disease, disorder or condition associated with a decreased level of SPD in a subject, or for pulmonary delivery of SPD, include administering the pharmaceutical composition to a subject in need of such treatment. |
| priorityDate |
2015-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |